Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

# AGENCY:

National Institutes of Health (NIH).

# ACTION:

Notice of Open Conference.

Notice is hereby given that the NIH, an agency of the Department of Health and Human Services, in collaboration with the Lupus Foundation of America, Washington, DC, will hold a scientific conference.

*Title:*                     “Systemic Lupus Erythematosus: From Mouse Models to Human Disease and Treatment.”                

*Dates:*                     September 2–3, 2010.                

*Location:*                     Lister Hill Auditorium, Building 38A, NIH, Bethesda, Maryland.                          ( print page 26267)    

## Purpose of the Meeting

*This meeting will bring basic research scientists working on models of autoimmune disease relevant to lupus together with clinicians treating lupus patients. There are numerous mouse models of lupus, but their relevance to the actual disease is still a subject for debate. Thus it is the purpose of this meeting to have participants discuss similarities, as well as differences, in mouse models with respect to the disease with the clinicians who actually treat patients. In addition, input is encouraged from clinical attendees regarding what markers in an animal model would be most important for monitoring the disease and assessing the effectiveness of treatment. It is hoped that one consequence of this meeting might be some consensus as to what is most important in any animal model and what animal models might be most useful in developing new markers and treatments for the disease. For more information, including the agenda and registration for this conference, please see http://web.ncifcrf.gov/​events/​SystemicLupus/​default.asp.*

*Contacts:*

*Howard Young:*                     Senior Investigator, NCI, NIH; 301–846–5700;                     *younghow@mail.nih.gov.*

*Silvia Bolland:*                     Senior Investigator, NIAID, NIH; 301–443–3158;                     *sb455w@nih.gov.*

*Juan Rivera:*                     Senior Investigator, NIAMS, NIH; 301–496–7592;                     *riveraj@mail.nih.gov.*

*Lisa Begg:*                     Director of Research, ORWH, OD, NIH; 301–496–7853;                     *beggl@od.nih.gov.*

Dated: May 5, 2010.

Francis S. Collins,

Director, National Institutes of Health.

[FR Doc. 2010–11169 Filed 5–10–10; 8:45 am]

BILLING CODE 4140–01–P